[Cited FineTest Antibody] Current Research on Neutrophils and Cancer Treatment

FineTest antibody contributes to the research on neutrophils and cancer treatment.

Publication Details
Article Title: A neutrophil mimicking metal-porphyrin-based nanodevice loaded with porcine pancreatic elastase for cancer therapy
Journal Title: Nature Communications
DOI: 10.1038/s41467-023-37580-z
IF: 17.694
PMID: 37031242

Abstract:   Precise discrimination and eradication of cancer cells by immune cells independent of antigen recognition is promising for solid tumor therapeutics, yet remains a tremendous challenge. Inspired by neutrophils, here we design and construct a tumor discrimination nanodevice based on the differential histone H1 isoform expression. In this nanodevice, neutrophil membrane camouflage and glutathione (GSH)-unlocking effect on Fe-porphyrin metal-organic framework structure ensures selectivity to cancer cells. The released porcine pancreatic elastase (PPE) simulates neutrophils' action to induce histone H1 release-dependent selective cancer cell killing. Meanwhile, nuclear localization signal (NLS) peptide-tagged porphyrin (porphyrin-NLS) acts as in-situ singlet oxygen (1O2) generator to amplify histone H1 nucleo-cytoplasmic translocation by inducing DNA double-strand breaks (DSBs) under laser irradiation, further promoting elimination of cancer cells. The overexpressed histone H1 isoform in cancer cells improves selectivity of our nanodevice to cancer cells. In vivo studies demonstrate that our design can not only inhibit primary tumor growth, but also induce adaptive T-cell response-mediated abscopal effect to against distal tumors.

Keywords:  Cancer Treatment, Neutrophils, Pancreatic Elastase, Glutathione, Histones, Protein Isoforms

FineTest Product Detection Target
HRP-conjugated Affinipure Goat Anti-Mouse IgG (H+L)(FNSA-0003) IgG
HRP-conjugated Affinipure Goat Anti-Rabbit IgG (H+L)(FNSA-0004) IgG

Validated Image

Cancer Treatment

Figure Source:  Nat Commun. 2023 Apr 8;14(1):1974. doi: 10.1038/s41467-023-37580-z.